Blod.in, a health-tech startup based in Chennai, secured an undisclosed amount in pre-seed funding. The deal was facilitated by Tamilpreneur, led by Shyam Siddarth, Founder & CEO and Praveen Krishna, Co-founder & CMO. Prabhu Rangarajan (Co-Founder of M2P Fintech), Mohan K (Co-Founder/CEO of IppoPay),Vijay Pravin (Co-Founder/CEO of bitsCrunch), Ashok Vardharajan (CTO of bitsCrunch), Savitha Ramasamy (Senior Scientist, Institute for Infocomm Research, A*Star), Karthick Sivaram (Co-Founder Backspace Tech), Mohammed Farouk (Vice-President at Rela Institute), and Bhopan Krishnan (Founder of Outline Systems) have also invested in the startup.
As a B2B company, Blod aims to manage healthcare data better. They have partnered with several hospitals and blood banks across Chennai to revolutionise the healthcare sector while focusing on the haematology department. They have just introduced the beta version of their flagship product, Blod+, as the first step to meeting hospitals’ haematology needs.
According to the founder and social entrepreneur Varun Nair, “The healthcare sector is currently highly unstructured. Blod simplifies and digitises the day-to-day activities of the haematology department of hospitals. Implementing a simple change like Blod makes blood management more efficient and effective.”
One of the investors, Vijay Pravin, Co-founder & CEO of bitsCrunch, says, “There are some investments you make from the pocket and some you make from the heart. Blod is one such team that could save many lives by bridging the gap between technology and blood scarcity in a country like India.”
Blod plans to scale up and invest in infrastructure, expansions, and technology stacks with the capital raised. Blod is committed to positively impacting the healthcare community with innovation that can transform and aid the healthcare system in providing patients with the human body’s lifeline – blood.
Blod.in, a health-tech startup based in Chennai caters to the haematology department by connecting hospitals and blood banks. They aim to develop a centralised blood management system.